Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 68, Issue 6, 2003, Pages 387-398

  Watkins, Bruce A ^a   Li, Yong ^a   Lippman, Hugh E ^a   Feng, Shulin ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Bone; Omega 3 fatty acids; Osteoblast; PGE2

Indexed keywords

CORE BINDING FACTOR; CYCLOOXYGENASE 2; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2;

BONE METABOLISM; BONE MINERAL; CALVARIA; CELL FUNCTION; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVITY; IN VIVO STUDY; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0037974182     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(03)00063-2     Document Type: Conference Paper

References (66)

1. R. Uauy, D.R. Hoffman, P. Peirano, et al., Essential fatty acids in visual and brain development, Lipids 36 (2001) 885-895.
2. S.H. Werkman, S.E. Carlson, Arandomized trial of visual attention of preterm infants fed docosahexaenoic acid until nine months, Lipids 31 (1996) 91-97.
3. E.E. Birch, D.R. Hoffman, R. Uauy, et al., Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants, Pediatr. Res. 44 (1998) 201-209.
4. U. Suchner, U. Senftleben, Immune modulation by polyunsaturated fatty acids during nutritional therapy: interactions with synthesis and effects of eicosanoids, Infusionsther. Transfusionsmed. 21 (1994) 167-182.
5. P.C. Calder, Dietary modification of inflammation with lipids, Proc. Nutr. Soc. 61 (2002) 345-358.
6. A. Gil, Polyunsaturated fatty acids and inflammatory diseases, Biomed. Pharmacother. 56 (2002) 388-396.
7. M.J. James, L.G. Cleland, Dietary n-3 fatty acids and therapy for rheumatoid arthritis, Semin. Arthritis Rheum. 27 (1997) 85-97.
8. S. Endres, R. Lorenz, K. Loeschke, Lipid treatment of inflammatory bowel disease, Curr. Opin. Clin. Nutr. Metab. Care 2 (1999) 117-120.
9. J.R. Hibbeln, N. Salem Jr., Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy, Am. J. Clin. Nutr. 62 (1995) 1-9.
10. Dietary fats: total fat and fatty acids, in: Dietary Reference intakes - Energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids, The National Academies Press, Washington, DC, 2002, pp. 8-1-8-97.
11. Dietary fats: total fat and fatty acids, in: Dietary Reference Intakes - Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids, The National Academies Press, Washington, DC, 2002, pp. 11-1-11-87.
12. R.E. Wuthier, Involvement of cellular metabolism of calcium and phosphate in calcification of avian growth plate cartilage, J. Nutr. 123 (1993) 301-309.
13. S.C. Marks Jr., S.C. Miller, Prostaglandins and the skeleton: the legacy and challenges of two decades of research, Endocrine J. 1 (1993) 337-344.
14. D.J. Baylink, R.D. Finkelman, S. Mohan, Growth factors to stimulate bone formation, J. Bone Miner. Res. 8 (1993) S565-S572.
15. M.C. Kruger, H. Coetzer, R. de Winter, et al., Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis, Aging 10 (1998) 385-394.
16. M.C. Kruger, D.F. Horrobin, Calcium metabolism, osteoporosis and essential fatty acids: a review, Prog. Lipid Res. 36 (1997) 131-151.
17. N. Claassen, H. Coetzer, C.M. Steinmann, M.C. Kruger, The effect of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats, Prostaglandins Leukot. Essent. Fatty Acids 53 (1995) 13-19.
18. K. Shichikawa, Y. Takenaka, A. Maeda, et al., A longitudinal population survey of rheumatoid arthritis in a rural district in Wakayama, Ryumachi 21 (Suppl) (1981) 35-43.
19. W.E. Lands, Eicosanoids and health, Ann. N.Y. Acad. Sci. 676 (1993) 46-59.
20. K. Igarashi, J.T. Woo, P.H. Stern, Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro, Biochem. Pharmacol. 63 (2002) 523-532.
21. L.G. Darlington, T.W. Stone, Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders, Br. J. Nutr. 85 (2001) 251-269.
22. J.M. Kremer, n-3 fatty acid supplements in rheumatoid arthritis, Am. J. Clin. Nutr. 71 (2000) 349S-351S.
23. G. Priante, L. Bordin, E. Musacchio, et al., Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid, Clin. Sci. 102 (2002) 403-409.
24. C.L. Curtis, S.G. Rees, C.B. Little, et al., Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids, Arthritis Rheum. 46 (2002) 1544-1553.
25. U.N. Das, Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids, Exp. Biol. Med. 227 (2002) 88-93.
26. K.E. Armour, R.J. van't Hof, P.S. Grabowski, et al., Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis, J. Bone Miner. Res. 14 (1999) 2137-2142.
27. H.A. Weiler, S.C. Fitzpatrick-Wong, Modulation of essential (n-6):(n-3) fatty acid ratios alters fatty acid status but not bone mass in piglets, J. Nutr. 132 (2002) 2667-2672.
28. B. Baggio, Fatty acids, calcium and bone metabolism, J. Nephrol. 15 (2002) 601-604.
29. 2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone, Biochem. Biophys. Res. Commun. 166 (1990) 208-216.
30. 2 in the inhibition of osteocalcin synthesis by human osteoblast-like cells in response to cytokines and systemic hormones, Biochem. Biophys. Res. Commun. 167 (1990) 194-202.
31. 2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1, Prostaglandins Leukot. Essent. Fatty Acids 50 (1994) 169-172.
32. 2 synthesis in the clonal osteoblast-like cell line MC3T3-E1, Prostaglandins Leukot. Essent. Fatty Acids 56 (1997) 121-125.
33. 2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1), Arch. Oral Biol. 44 (1999) 233-241.
34. T.G. Atkinson, H.J. Barker, K.A. Meckling-Gill, Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats, Lipids 32 (1997) 293-302.
35. B.A. Watkins, Y. Li, K.G.D. Allen, et al., Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats, J. Nutr. 130 (2000) 2274-2284.
36. Y. Li, M.F. Seifert, D.M. Ney, et al., Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids, J. Bone Miner. Res. 14 (1999) 1153-1162.
37. Y. Iwami-Morimoto, K. Yamaguchi, K. Tanne, Influence of dietary n-3 polyunsaturated fatty acid on experimental tooth movement in rats, Angle Orthod. 69 (1999) 365-371.
38. N. Claassen, H.C. Potgieter, M. Seppa, et al., Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content, Bone 16 (1995) 385S-392S.
39. P. Ducy, R. Zhang, V. Geoffroy, et al., Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation, Cell 89 (1997) 747-754.
40. P. Ducy, M. Starbuck, M. Priemel, et al., A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development, Genes Dev. 13 (1999) 1025-1036.
41. C. Banerjee, L.R. McCabe, J.Y. Choi, et al., Runt homology domain proteins in osteoblast differentiation, J. Cell. Biochem. 66 (1997) 1-8.
42. B.A. Watkins, Y. Li, H.E. Lippman, M.F. Seifert, Omega-3 polyunsaturated fatty acids and skeletal health, Exp. Biol. Med. 226 (2001) 485-497.
43. P.J. Marie, Cellular and molecular alterations of osteoblasts in human disorders of bone formation, Histol. Histopathol. 14 (1999) 525-538.
44. D.J. Chang, C. Ji, K.K. Kim, et al., Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid, J. Biol. Chem. 273 (1998) 4892-4896.
45. X. Zhang, E.M. Schwarz, D.A. Young, et al., Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair, J. Clin. Invest. 109 (2002) 1405-1415.
46. K.L. Lee, J.E. Aubin, J.N. Heersche, Beta-glycerophosphate-induced mineralization of osteoid does not alter expression of extracellular matrix components in fetal rat calvarial cell cultures, J. Bone Miner. Res. 7 (1992) 1211-1219.
47. H. Ohgushi, Y. Dohi, T. Katuda, et al., In vitro bone formation by rat marrow cell culture, J. Biomed. Mater. Res. 32 (1996) 333-340.
48. T. Tsuji, F.J. Hughes, C.A. McCulloch, A.H. Melcher, Effects of donor age on osteogenic cells of rat bone marrow in vitro, Mech. Ageing Dev. 51 (1990) 121-132.
49. L.D. Quarles, D.A. Yohay, L.W. Lever, et al., Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development, J. Bone Miner. Res. 7 (1992) 683-692.
50. H. Sudo, H.A. Kodama, Y. Amagai, et al., In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria, J. Cell Biol. 96 (1983) 191-198.
51. B.A. Watkins, H.E. Lippman, L. Le Bouteiller, et al., Bioactive fatty acids: role in bone biology and bone cell function, Prog. Lipid Res. 40 (2001) 125-148.
52. J.Y. Lee, K.H. Sohn, S.H. Rhee, D. Hwang, Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4, J. Biol. Chem. 276 (2001) 16683-16689.
53. R.A. Coleman, W.L. Smith, S. Narumiya, Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes, Pharmacol. Rev. 46 (1994) 205-229.
54. 2 reduces arachidonic acid release in murine podocytes: evidence for an autocrine feedback loop, Am J Physiol. Cell Physiol. 284 (2003) 302-309.
55. B.E. Rapuano, R.S. Bockman, Activators of protein kinase A decrease the levels of free arachidonic acid in osteoblasts via stimulation of phosphatidylcholine and phosphatidylethanolamine synthesis, Prostaglandins Leukot. Essent. Fatty Acids 58 (1998) 147-156.
56. A. Bonazzi, M. Bolla, C. Buccellati, et al., Effect of endogenous and exogenous prostaglandin E-2 on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cells, Am. J. Respir. Crit. Care Med. 162 (2000) 2272-2277.
57. 2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2, J. Biol. Chem. 272 (1997) 19891-19897.
58. 1 subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells, Calcif. Tissue Int. 62 (1998) 327-331.
59. 3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner, Bone 24 (1999) 475-484.
60. 3 is mediated via protein kinase C-and protein kinase A-dependent pathways, Biomaterials 22 (2001) 731-741.
61. O.H. Lowry, N.R. Roberts, M.L. Wu, et al., The quantitative histochemistry of brain, J. Biol. Chem. 207 (1954) 19-37.
62. K. Sakaguchi, I. Morita, S. Murota, Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats, Prostaglandins Leukot. Essent. Fatty Acids 50 (1994) 81-84.
63. C.K. Schlemmer, H. Coetzer, N. Claassen, M.C. Kruger, Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat, Prostaglandins Leukot. Essent. Fatty Acids 61 (1999) 381-390.
64. P.G. Reeves, F.H. Nielsen, G.C. Fahey Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet, J. Nutr. 123 (1993) 1939-1951.
65. P. Albertazzi, K. Coupland, Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention?, Maturitas 42 (2002) 13-22.
66. C. Blank, M.A. Neumann, M. Makrides, R.A. Gibson, Optimizing DHA levels in piglets by lowering the linoleic acid to alpha-linolenic acid ratio, J. Lipid Res. 43 (2002) 1537-1543.